While mega caps have consumed much of investors’ attention in recent years creating extreme levels of market concentration, great things have been happening ‘behind the scenes’ at some of Europe’s lesser-known corporates. We’re discovering overlooked small-cap gems that offer both attractive portfolio diversification benefits and the potential for double-digit returns.
With a strong long-term growth potential and a distinct social angle, the life sciences sector is developing at a fast pace. Forward-thinking investors are looking for ways to enter this growing niche sector. But access is selective, and industry expertise isn’t enough to be successful. What does it take?